icon
icon
icon
icon
🏷️$300 Off
🏷️$300 Off

News /

Articles /

Pfizer Boosts Dividend Payout, Reflecting Strong Financial Performance

Julian WestSunday, Jan 19, 2025 9:16 am ET
3min read


Pfizer Inc. (NYSE: PFE), a leading global pharmaceutical company, has announced an increase in its quarterly cash dividend to $0.40 per share, effective for the first-quarter 2022 dividend. This marks the 333rd consecutive quarterly dividend paid by Pfizer, reflecting the company's strong financial performance and confidence in its current product portfolio and R&D pipeline. Dr. Albert Bourla, Pfizer Chairman and Chief Executive Officer, stated, "The increase in dividend is a direct reflection of our strong financial performance and continued confidence in our current product portfolio and R&D pipeline."



Pfizer's financial performance in 2022 was exceptional, with revenues reaching an all-time high of $100.3 billion, reflecting 30% operational growth. The company's reported diluted EPS (earnings per share) increased by 42% year-over-year, and adjusted diluted EPS grew by 62%. Pfizer's strong financial performance is a testament to the company's ability to deliver innovative medicines and vaccines that meet the needs of patients worldwide.

PFE Total Revenue interval growth rate, Basic EPS interval growth rate
单位


Pfizer's dividend increase is a positive signal for investors, demonstrating the company's commitment to returning value to shareholders. The company's dividend payout ratio for the three months ended in Sep. 2024 was 0.40, which is ranked better than 96.07% of 509 companies in the Drug Manufacturers industry. Pfizer's strong dividend history and commitment to returning value to shareholders make it an attractive investment option for income-oriented investors.



In conclusion, Pfizer's dividend increase reflects the company's strong financial performance and commitment to returning value to shareholders. With a robust product portfolio and R&D pipeline, Pfizer is well-positioned to continue delivering strong financial results and generating value for shareholders. As an income-oriented investor, Pfizer's dividend history and commitment to returning value to shareholders make it an attractive investment option.
Comments

Add a public comment...
Post
User avatar and name identifying the post author
AGNES MORALES
01/19

Weeks ago I started my trading journey with $1000 and didn’t have much experience. After few days of consistent work and following the recommendations of Elizabeth Towles on Whatsapp +1563 279-8487,I managed to grow my account to $8850

0
Reply
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
You Can Understand News Better with AI.
Whats the News impact on stock market?
Its impact is
fork
logo
AInvest
Aime Coplilot
Invest Smarter With AI Power.
Open App